MASH
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
8 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (5)
Total enrollment: 10,886 patients across 5 trials
Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis
Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants
A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH Liver Fibrosis
Global Research Initiative for Patients Screening on MASH
Related Jobs
Senior Director, Clinical Development Metabolism (MASH)
Area Business Manager- Los Angeles, CA
Global Development Medical Director
Regional Sales Director - South Central
Health Systems Regional Scientific Director
Sr. Director, MASH/ALD Brand Lead & Pipeline
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.